Differences in Adolescent Cannabis Use Disorder Treatment Across Europe
Author Information
Author(s): Phan Olivier, Henderson Craig E, Angelidis Tatiana, Weil Patricia, van Toorn Manja, Rigter Renske, Soria Cecilia, Rigter Henk
Primary Institution: Centre Emergence, Institut Mutualiste Montsouris, Paris, France
Hypothesis
Do the populations of adolescents with cannabis use disorder differ across various European youth care sites?
Conclusion
The study found significant differences in baseline characteristics of adolescents with cannabis use disorder across different European sites, largely explained by referral sources.
Supporting Evidence
- Adolescents were recruited from local populations seeking treatment for cannabis use disorder.
- Referral sources varied significantly across sites, affecting the demographics of participants.
- Most differences in baseline characteristics disappeared when accounting for referral source.
Takeaway
This study looked at teens in Europe who use cannabis and found that where they come from affects their treatment options and backgrounds.
Methodology
The INCANT trial was a multicentre phase III(b) randomized controlled trial comparing Multidimensional Family Therapy (MDFT) with treatment as usual (TAU) across five European sites.
Potential Biases
Differences in local treatment cultures and referral practices may introduce bias in participant selection and treatment outcomes.
Limitations
The study's findings may not be generalizable beyond the specific sites involved in the trial.
Participant Demographics
Participants were adolescents aged 13-18 with cannabis use disorder, with a majority being male and varying rates of foreign descent across sites.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website